Coagulation Factor IX Protein (F9)

Catalog No. ABIN4888463

Product Details

Target: Coagulation Factor IX (F9)

Protein Type: Native

Origin: Human

Source: Human

Characteristics: Purified native Human Factor IX protein
Protein Source: Human plasma

Purity: > 95 % pure

Application Details

Application Notes: Each Investigator should determine their own optimal working dilution for specific applications.

Restrictions: For Research Use only

Handling

Buffer: 20mM Tris-HCL, 0.1M NaCl, 1mM Benzamidine pH 7.4

Preservative: Benzamidine

Precaution of Use: This product contains Benzamidine: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Handling Advice: Avoid repeated freeze/thaw cycles.

Storage: -80 °C

Target Details

Target: Coagulation Factor IX (F9)

Alternative Name: Factor IX (F9 Products)

Synonyms: AA407498 Protein, AI506714 Protein, AK-3 Protein, Ak3l Protein, Ak3l1 Protein, Akl3l Protein, FIX Protein, HEMB Protein, P19 Protein, PTC Protein, THPH8 Protein, AW111646 Protein, Cf-9 Protein, Cf9 Protein, f9 Protein, zgc:109775 Protein, fix Protein, ptc Protein, hemb Protein, FIXA Protein, zgc:136807 Protein, adenylate kinase 3 Protein, coagulation factor IX Protein, coagulation factor IXa Protein, coagulation factor 9 Protein, coagulation factor 9 S homeolog Protein, Coagulation factor IX Protein, coagulation factor IXb Protein, Ak3 Protein, F9 Protein, f9a Protein, f9 Protein, CpipJ_CPIJ003776 Protein, CpipJ_CPIJ009129 Protein, CpipJ_CPIJ013063 Protein, CpipJ_CPIJ013624 Protein, Tsp_01441 Protein, f9.S Protein, fa9 Protein, f9b Protein

Background: Factor IX is a vitamin K-dependent glycoprotein produced in the liver. Plasma concentration of F.IX is normally around 5 ug/ml (87 nM) in plasma. The biological importance of F.IX is demonstrated in Haemophilia B an X-linked congenital bleeding disease resulting from a quantitative or qualitative defect in F.IX function.
Description: Human plasma.
Alternative Names: Complement Factor IX

Molecular Weight: 56 kDa